IOP Medical

Company Overview

Snapshot

Founded in June 2016 by Prof. Yossi Mandel, IOP Medical operates with 1–10 employees. The company has secured funding from 2 investors across one funding round, with G.O Innovation and Stanford University participating. IOP Medical is developing an implantable sensor for self-monitoring of intraocular pressure, leveraging technology patented at Stanford University.

Business overview

IOP Medical is an ophthalmology startup focused on developing an implantable sensor for self-monitoring of intraocular pressure. The core technology, developed and patented at Stanford University, enables users to monitor their intraocular pressure using a simple smartphone camera. The company operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare and medical devices for chronic patients, particularly those with glaucoma, and serves global markets.

Company Intelligence Q&A

What is IOP Medical's core technology?

IOP Medical is developing an implantable sensor for self-monitoring of intraocular pressure, utilizing technology patented at Stanford University. This device allows users to monitor their condition with a smartphone camera.

Who founded IOP Medical and when?

IOP Medical was founded in June 2016 by Prof. Yossi Mandel, who also serves as the Chief Scientist and Inventor.

Which investors participated in IOP Medical's funding round?

In January 2019, IOP Medical received funding from G.O Innovation and Stanford University.

What markets does IOP Medical target?

IOP Medical targets the global market, focusing on digital healthcare and medical devices for chronic patients, particularly those with glaucoma, through remote monitoring solutions.

What is the current product stage of IOP Medical?

IOP Medical's product is currently in the R&D stage, focusing on the development of its implantable sensor technology.